The Therapeutic Goods Administration grants provisional approval to the Moderna COVID-19 vaccine for children aged 12 to 17 years old.
Sources: 9 News
Sources: 9 News
Moderna, the Takeda Pharmaceutical Company, and Spanish drug maker Rovi issue a joint statement indicating that they have found particles of stainless steel in some vaccine vials, but that the particles did not pose any additional health risks. The companies also state that they are working with the Japanese government to recall three suspended batches of the vaccine.
Washington, D.C. announces that they will require healthcare workers and other health-related professionals to be vaccinated with at least a first dose of the Pfizer–BioNTech or Moderna vaccine or a single-dose Janssen vaccine by September 30.
Ireland opens registration for children between the ages of 12 and 15 to receive a COVID-19 vaccine. Around 280,000 children will be eligible for vaccination with the Pfizer–BioNTech or Moderna vaccines, with more than 50,000 already registered.
Italy suspends the use of the Oxford-AstraZeneca vaccine in people under the age of 60 nationwide following the death of an 18-year-old woman yesterday and reports of other young people who have been hospitalized in critical condition after receiving their first dose of the vaccine. The Moderna and Pfizer vaccines will be used for the vaccination of people under the age of 60, including for people who already received a first dose of the AstraZeneca vaccine.
White House COVID-19 Response Coordinator Jeffrey Zients says that the Biden administration will accelerate doses of the Pfizer-BioNTech and Moderna vaccines. The move comes after the United States suspended usage of the Johnson & Johnson vaccine.